Skip to content
healthcare.dev
Get a free key

Lynavoy

NDC 69516-140, Linerixibat, tablet, film coated, from Intercept Pharmaceuticals Inc.

Product NDC
69516-140
Status
Listed
Labeler
Intercept Pharmaceuticals Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA220295
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69516-140 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LINERIXIBAT40 mg/1

Pharmacologic classes

Ileal Bile Acid Transporter Inhibitor [EPC]; Ileal Bile Acid Transporter Inhibitors [MoA]

Package NDCNDC-11Package
69516-140-606951601406060 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69516-140-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c00317c8-709c-4707-a6d1-632bff123026

Use it

Look up 69516-140 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69516-140 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69516-140. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.